On September 15, 2022, the "Ernst & Young Fudan Most Potential Enterprise Award Ceremony 2022 and High Growth Enterprise Theme Seminar" hosted by Ernst & Young, one of the world's leading professional services networks, and the School of Management of Fudan University, a top university in China, kicked off in Shanghai. The "EY Fudan Most Potential Enterprises" awardees which has attracted much attention from different industries was officially announced. After authoritative, professional, and strict screening, Evergreen Therapeutics – with its reliance on the core founding and management team composed of FDA reviewers and the industry's top clinical research and development and AI/quantum technology teams with decades of experience in new drug research and development, its R&D and business models as well as high-speed pipeline R&D progress – was one of the companies that stood out and won the "Ernst & Young Fudan Most Potential Enterprise Award".

Dr. Tom Du (fourth from the right), Chairman of Evergreen Therapeutics, toasts with other guests during the award ceremony

Evergreen Therapeutics always adheres to its original intention of focusing on urgent Clinical needs, achieving medical value, and benefiting patients around the world. It innovatively uses "end-to-end" AI technology and develop First-in-Class drugs with urgent clinical needs in a innovative way, improving the efficiency and success rate of drug development. The company focuses on the research and development of drugs in the fields of immunity and ophthalmology, and it has developed rapidly. After only 3 years from its establishment, 5 candidate drugs out of 10 pipelines have obtained clinical clearance from the US FDA. Among the pipelines，EG-301 is the representative of company’s next-generation AI/quantum-designed drugs which took only less than 18 months to advance from preclinical to clinical phase II.

This year's judging committee was composed of partners of Ernst & Young China's member institutions and senior experts and scholars from the School of Management of Fudan University. The selection was held for 12 years. With its meticulous selection criteria, it has become an activity of extensive social influence and profound economic significance. This award is undoubtedly a powerful affirmation of Evergreen’s existing achievements and future potential for development in its industry.